| |
October 16-18, 2023 | Boston, MA
|
|
Today's Big NewsJul 19, 2023 |
| By James Waldron Pfizer has licensed a preclinical cardiovascular program from Riparian Pharmaceuticals as part of an agreement that will also see the Big Pharma support further discovery efforts by the biotech. |
|
|
|
| July 18-19, 2023 | Jersey City, NJ |  |
|
|
By Max Bayer 9 Meters Biopharma has filed for bankrupty, reporting just $152,000 in cash on hand. The company was working on advancing a metabolic pipeline after a late-stage failure in 2022. |
By James Waldron Being “catfished”—a term for impersonating someone else online, usually to lure a romantic partner—has long been a problem in the shadowy world of social media. But not even biotechs are immune from the phenomenon of identity theft, as AIM ImmunoTech learned this week. |
Sponsored by Altasciences Optimize Your Drug Development Timeline With This Dosage Form Can you name five benefits of using liquid-filled, hard-shell capsules in drug development over other solid oral dosage forms? Find out! |
|
Hear DDI expert, Dr. Brian Ogilvie, discuss important takeaways from the upcoming global guidance in this valuable presentation... View Symposium Recording >> 
|
|
By James Waldron Faron Pharmaceuticals has pointed to the latest snapshot of early-stage data as proof that its tumor-associated macrophage candidate bexmarilimab is ready to enter phase 2 trials this year. |
By Helen Floersh Mpox may no longer be a public health emergency, but the disease is here to stay. Blue Water Biotech is one of the few biotechs trying to build a better vaccine. |
By Gabrielle Masson,Max Bayer,Annalee Armstrong Alongside the new year, we've launched a new Fierce Biotech Fundraising Tracker to keep the pulse on the industry's financing. |
By Conor Hale The two companies aim to get ahead of potentially high patient demand as advancements are made in hopefully treating the neurodegenerative condition. |
By Noah Tong CMS could remove PET scan restrictions that limit just one brain scan per clinical trial to better determine whether new Alzheimer's drugs are slowing cognitive decline. |
By Kevin Dunleavy Johnson & Johnson has hopped on the litigation bandwagon, becoming the fourth Big Pharma company to sue the U.S. government over drug price negotiations in the Inflation Reduction Act. In U.S. District Court in New Jersey, J&J claimed that price negotiations by Medicare would violate the First and Fifth Amendments of the U.S. Constitution. |
By Conor Hale Abiomed has identified 27 cases where the stentlike struts on the outer edge of the TAVR implant have connected with the Impella’s spinning blades. |
By Joseph Keenan Signant Health acquired fellow trial data specialist DSG for an undisclosed price as part of its plans to expand service offerings for site-based and decentralized clinical trials. |
By Ben Adams Pharmaceutical drugs made up half of the most-seen new brands by TV ad impressions for the first half of 2023 as the industry looks to boost awareness of its newest offerings. |
By Dave Muoio A recent extrapolation of Virginia weather trends and care utilization data suggests that about 234,000 excess emergency department visits and 56,000 hospital admissions occur nationwide due to heat event days. |
Fierce podcasts Don't miss an episode |
| This week on "Podnosis," we talk about how reprocessing medical devices can reduce waste. Also under discussion is the role of choice architecture in value-based care. |
|
|---|
|
|
|
Tuesday, July 25, 2023 1pm ET / 10am PT New methods in scalable compute cloud environments not only accelerate drug discovery in a cost-effective manner, but benefit from reduced deployment time, accelerated GPU speed, and reduced infrastructure costs. Register now to learn more. 
|
|
Whitepaper Leading facilities practices and technologies can help improve the productivity of your research and manufacturing operations—and accelerate the journey from laboratory to saving lives. Sponsored by: JLL |
Webinar Download this webinar to learn how to avoid pitfalls when characterizing CAR-T cells in your development workflow, how to save time by using one antibody to examine your entire panel of CARs, and more. Sponsored by: Cell Signaling Technology |
Whitepaper Learn more about the current challenges and issues that eClinical technology providers are facing. Sponsored by: YPrime |
Research The right sourcing strategy can help save of millions of dollars—learn about developing a strategy for sourcing the cGMP chemicals critical to your processes. Sponsored by: Thermo Fisher Scientific Production Chemicals and Services |
Whitepaper Learn how a GPCR-focused library with a cell-based biopanning strategy led to the discovery of 13 high-affinity and selective anti-GLP-1R antibodies with highly developable therapeutic properties. Sponsored by: Twist Bioscience |
eBook This eBook identifies the trends driving major change in the Medical Affairs (MA) function. It also outlines the strategic and tactical implications for MA leaders and team members. Sponsored by: Blue Matter, strategic consultants in the life sciences |
eBook Take a look at the reporting tools sponsors need to access insights earlier in the clinical trial enrollment funnel, so you can take informed actions. Sponsored by: OneStudyTeam |
Whitepaper Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your bioprocessing workflows. Sponsored by: Thermo Fisher Scientific Production Chemicals and Services |
| July 18-19, 2023 | Jersey City, NJ |
|
|
| |
|
